A Test Case on Sanity of Drug Prices By Pramod John A new Hepatitis C drug is better for the patient, more effective and costs far less. What will it say if the drug doesn't succeed?
Creative ideas needed for solving opioid epidemic By Paul Carroll Journalists are going to be naming names on the opioid crisis and telling stories of those killed or crippled. McKesson, Cardinal Health and Amerisource Bergen are already being singled out.
How to Save Individual ACA Market By David Axene Persons with preexisting conditions are not insurable risks. Trying to accommodate them in insurance market risk pools is bound to fail.
10 Ideas That Could Fix Healthcare By Fred Goldstein We have to hold the organizations that we fund accountable; too many of them exist to exist and offer limited value.
Navigating Telehealth for HR and Employers By Robb Leigh While all serious cases should be addressed in person, there are far more minor cases that can be safely treated via telemedicine.
6 Shocking Facts on Opioid Abuse By Al Lewis The $78 billion all-in cost in the U.S. of opioid use, abuse and treatment works out to about $756 per employee per year.
Health Consumerism, Stress Management By Ronald Bachman Without a structured stress management program, employees will deal with stress in other ways (e.g. comfort food, alcohol, drugs, smoking).
Big Data? How About Quality Data? By Paige Swanepoel Quality data is driving actionable insights for health insurance innovators to improve choice, transparency and user experience.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.